Viking Therapeutics VKTX FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Viking Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Viking Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viking Therapeutics's fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viking Therapeutics's FX effect on cash?
- Viking Therapeutics (VKTX) reported FX effect on cash of $16K in Q1 2026.
- How has Viking Therapeutics's FX effect on cash changed year-over-year?
- Viking Therapeutics's FX effect on cash increased by 1500.0% year-over-year, from $1K to $16K.
- What does FX effect on cash mean?
- The impact of exchange rate changes on the value of cash and equivalents held in foreign currencies.